Tenax Therapeutics (TENX) Stock Price, Quote, News & History | Benzinga

SPY764.52+0.25%QQQ744.46+0.63%BTC/USD83,741.19+0.22%DIA508.08−0.09%GLD381.82+0.26%TLT77.27−0.26%

Tenax Therapeutics Inc (TENX) Stock Price, Quote, News & History

TENXNASDAQ

Trade with Public

Trade with Public

$1.89

0.052.72%

Last update: Oct 1, 6:23 AM

$1.91

0.073.8%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$1.89

Volume / Avg.

8.16K / 5.40M

Day Range

- - -

52 Wk Range

1.31 - 19.40

Market Cap

$50.66M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

21%

Days to Cover

1.03

Recent Tenax Therapeutics Inc News

5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month

U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 350 points during the session. Renewed US-Iran strikes over the weekend sent crude sharply higher Monday, reviving inflation fears and

Avi Kapoor

This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst

Avi Kapoor

Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge

US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.

Avi Kapoor

Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback

Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.

Vandana Singh

US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results

Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-46.03M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

58.54M

Free Cash Flow (TTM)

-46.03M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

12.51M

Analyst Trends and Forecast

4

Jun

5

Jul

2

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$47.24M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.62

Earnings Yield % (TTM)

-78.31%

Earnings Yield % (FWD)

-81.22%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$117.98M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-